Results 211 to 220 of about 8,505 (243)

Psychedelics and hypnosis: Commonalities and therapeutic implications [PDF]

open access: yesJournal of Psychopharmacology, 2018
Background Recent research on psychedelics and hypnosis demonstrates the value of both methods in the treatment of a range of psychopathologies with overlapping applications and neurophenomenological features.
Clement E Lemercier, Devin B Terhune
exaly   +2 more sources

Psychedelics as Transformative Therapeutics

American Journal of Psychiatry, 2023
Over the past decade, psychedelic compounds have emerged as potentially transformative therapeutics for a variety of intractable neuropsychiatric conditions. However, historically most of the basic science has utilized these compounds as probes to interrogate various endogenous neurotransmitter systems-mainly the serotonin 5-HT2A receptor.
Bryan L, Roth, Ryan H, Gumpper
openaire   +2 more sources

Psychedelic fungi

Current Biology
Several species of fungi, collectively known as 'psychedelic fungi', produce a range of psychoactive substances, such as psilocybin, ibotenic acid, muscimol and lysergic acid amides. These substances interact with neurotransmitter receptors in the human brain to induce profound psychological effects.
Jason, Slot, Dirk, Hoffmeister
openaire   +2 more sources

Psychedelic Sacraments

Journal of Psychoactive Drugs, 2005
The use of psychedelic substances within a context that emphasizes religious experiences and aims to provide spiritual insights is not a new phenomenon. However, the proscription of these substances in most modern societies leads to such use now typically occurring in an underground and idiosyncratic manner that often leaves individuals on their own ...
openaire   +2 more sources

Compassionate use of psychedelics

Medicine, Health Care and Philosophy, 2020
In the present paper, we discuss the ethics of compassionate psychedelic psychotherapy and argue that it can be morally permissible. When talking about psychedelics, we mean specifically two substances: psilocybin and MDMA. When administered under supportive conditions and in conjunction with psychotherapy, therapies assisted by these substances show ...
Adam Greif, Martin Šurkala
openaire   +2 more sources

The history of psychedelics and why psychedelic stories matter

Open Access Government, 2023
The history of psychedelics and why psychedelic stories matter Erika Dyck argues that how people learn about psychedelics today matters, based on the histories of these drugs and how they have been and should be used in clinical medicine.
openaire   +1 more source

Psychedelics

The term psychedelic was formally introduced in 1957 to mean “mind manifesting” or “to bring to light,” but the phenomenon of seeking nonordinary states of consciousness has long and diverse roots. Psychedelic substances are associated with plants, fungi, animals, and synthetic substances that can cause changes in consciousness and hallucinations ...
  +5 more sources

The polypharmacology of psychedelics reveals multiple targets for potential therapeutics

open access: yesNeuron
The classical psychedelics (+)-lysergic acid diethylamide (LSD), psilocybin, and mescaline exert their psychedelic effects via activation of the 5-HT2A serotonin receptor (5-HT2AR).
Gumpper, Ryan H.   +20 more
exaly   +2 more sources

Psychedelics

Journal of Psychiatric Practice, 2023
openaire   +2 more sources

Why Psychiatry Needs Psychedelics and Psychedelics Need Psychiatry

Journal of Psychoactive Drugs, 2014
Without researching psychedelic drugs for medical therapy, psychiatry is turning its back on a group of compounds that could have great potential. Without the validation of the medical profession, the psychedelic drugs, and those who take them off-license, remain archaic sentiments of the past, with the users maligned as recreational drug abusers and ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy